Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective, multicenter, double-blind, randomized, placebo-controlled, Phase
Ib/IIa clinical study to assess the administration of ApTOLL together with endovascular
therapy in acute ischemic stroke patients who are candidates to receive reperfusion
therapies.